PT  - JOURNAL ARTICLE
AU  - Andrii Orfin
AU  - Marina Starykovych
AU  - Tamila Alexanyan
AU  - Svitlana Tkachuk
AU  - Anatoliy Starodub
AU  - Taras Luchyshyn
AU  - Andriy Sibirny
AU  - Serhiy Souchelnytskyi
AU  - Yuriy Kit
TI  - TCA-soluble blood serum proteins of COVID-19 patients as possible predictive markers for the disease severity
AID  - 10.1101/2021.04.07.21255063
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.07.21255063
4099  - http://medrxiv.org/content/early/2021/04/09/2021.04.07.21255063.short
4100  - http://medrxiv.org/content/early/2021/04/09/2021.04.07.21255063.full
AB  - Coronavirus disease 19 (COVID-19) is a global health crisis on a planetary scale. COVID-19 in many people has mild or moderate manifestation, although significant number of people, especially the elderly, suffer heavy from this illness, which often resulting in death. There are reports of similarities in immune response between COVID-19 and some autoimmune diseases. Earlier, we have demonstrated that fraction of TCA-soluble blood serum proteins containing a 48 kDA fragment of unconvential Myosin C1 have linked with development of multiple sclerosis and rheumatoid arthritis. Here we analyze use of these proteins in determining the severity of disease in COVID-19 patients. We found that blood serum of COVID-19 patients in acute disease manifestation contains, in contrast to healthy individuals, the TCA-soluble proteins with molecular masses 48 kDa and 76 kDA which were identified as a short form of unconventional myosin 1c and a modified form of human serum albumin.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Сommission of bioethical examination of Institute of Cell Biology, National Academy of Sciences of Ukraine Head of Commission, Oleh Stasyk, Ph.D Head of Department of Cell Signaling Members of the commission: Rostyslav Stoika, Ph.D, Professor Head of Department of Regulation of Cell Proliferation and Apoptosis Maxym Lutsyk, Ph.D, MD,Professor Leading Researcher of Department of Regulation of Cell Proliferation and Apoptosis Yaroslav Bobak Ph.D. Senior Researcher of Department of Cell Signaling All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available https://www.researchgate.net TCA2,2,2-trichloroacetic acid